| 标题 |
Addition of ipilimumab to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma (PRODIGE 81-FFCD 2101-TRIPLET HCC): phase 2 results from a randomised, multicentre, open-label, phase 2–3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Gastroenterology & Hepatology 作者:Philippe Merle; Jean-Frederic Blanc; Karine Le Malicot; Jean-Marie Peron; Vincent Bourgeois; et al 出版日期:2026-06-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)